Acquisition · Activity not yet classified
Aspirion
Transaction overview
Reported completed
Exact closing date not established.
On August 2, 2022, Linden Capital Partners reported that it had completed its majority acquisition of Aspirion, following the June 21 agreement. Aquiline and management were continuing investors under the agreement; Varsity Healthcare Partners joined as a minority shareholder. The completion report does not establish the exact closing day.
Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.
Source evidence
- Linden Announces Agreement to Acquire Majority Stake in Aspirion ↗
Linden Capital Partners · Published Jun 21, 2022
June 21 agreement for majority investment; management and Aquiline remain investors; closing conditions.
- Linden Completes Aspirion Acquisition ↗
Linden Capital Partners · Published Aug 2, 2022
August 2 completion report; Varsity minority ownership; exact closing day unstated.